||**Evexia Foundation**|**Evexia Foundation**|**Evexia Foundation**|**1176962**|**1176962**|**1176962**|**CC16a**|
|---|---|---|---|---|---|---|---|
||**For the period**<br>**from**|Period start date<br>01-Aug-24|**To**||Period end date<br>31-Jul-25|||
|||||||||
|**Section A Receipts and payments**||||||||
|**A1 Receipts**|**Unrestricted**<br>**funds**<br>**to the nearest**<br>**£**<br>**2,424.00**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**2,424.00**<br>**-**<br>**-**<br>**-**<br>**2,424**<br>**282.96**<br>**1,365.00**<br>**420.20**<br>**1,000.00**<br>**528.00**<br>**196.07**<br>**-**<br>**-**<br> **3,792.23**<br>**-**<br>**-**<br> **-**<br>**3,792.23**<br>**-            1,368.23**<br>**-**<br>**7,447.79**<br>**6,079.56**|**Restricted**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**Endowment**<br>**funds**<br>**to the nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**||**Total funds**<br>**to the nearest £**<br>**2,424**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**2,424**<br>**-**<br>**-**<br>**-**<br>**2,424**<br>**283**<br>**1,365**<br>**420**<br>**1,000**<br>**528**<br>**196**<br>**-**<br>**-**<br>**-**<br>**3,792**<br>**-**<br>**-**<br>**-**<br>**3,792.23**<br>**-            1,368.23**||**Last year**<br>**to the nearest £**|
|Donations|**2,424.00**||||||**-**|
|Bank compensation|||||||**-**|
|Grant|**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
|**_Sub total_**_(Gross income for_<br>_AR)_|**2,424.00**||||||**-**|
|||||||||
|**A2 Asset and investment sales,**<br>**(see table).**||||||||
||**-**|||||||
||**-**||||||**-**|
|**_Sub total_**|**-**||||||**-**|
|**_Total receipts_**<br>**A3 Payments**||||||||
||||||||**-**|
|||||||||
|Website and IT costs|**282.96**||||||**-**|
|Venue hire|**1,365.00**||||||**-**|
|Equipment|**420.20**||||||**-**|
|Teacher services|**1,000.00**||||||**-**|
|Training/Research and Development|**528.00**||||||**-**|
|Admin and Consultation|**196.07**||||||**-**|
|Social media / Promo and Marketing|||||||**-**|
||**-**||||||**-**|
||**-**||||||**-**|
|**_Sub total_ **|**3,792.23**||||||**-**|
|||||||||
|**A4 Asset and investment**<br>**purchases, (see table)**||||||||
||**-**|||||||
||**-**|||||||
|**_Sub total_ **|**-**||||||**-**|
|**_Total payments_**<br>**_Net of receipts/(payments)_**<br>**A5 Transfers between funds**<br>**A6 Cash funds last year end**<br>**_Cash funds this year end_**||||||||
||||||||**-**|
|||||||||
||**-            1,368.23**|**-**|**-**||**-            1,368.23**||**-**|
||**-**|**-**|**-**||**-**||**-**|
||**7,447.79**||**-**||**7,447.79**||**-**|
||**6,079.56**|**-**|**-**||**6,079.56**||**-**|



CCXX R1 accounts (SS) 

04/09/2025 

1 



## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>Signed by one or two trustees on<br>behalf of all the trustees<br>**B5 Liabilities**<br>**B3 Investment assets**<br>**B2 Other monetary assets**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>**B1 Cash funds**<br>CCXX R2 accounts (SS)|**Details**<br>**Details**<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))<br>Bank<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>~~2~~|**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**6,079.56**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**6,079.56**<br>**-**<br>OK<br>OK<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**asset belongs**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Wendyvan der Haagen Boyd<br>ClareKenvyn|**Endowment**<br>**funds**<br>**to nearest £**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**Endowment**<br>**funds**<br>**to nearest £**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||||02-Sep-25|
||||02-Sep-25<br>|
||||~~04/09/2025~~|



CCXX R2 accounts (SS) 

